In-vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 1, 1996, Pages 155-160

  Aubert, G ^a   Guichard, D ^a   Vedel, G ^b  

^a SERVICE DE NEUROLOGIE   (France)

^b CHU Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFEPIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORINASE; IMIPENEM; MEROPENEM; PENICILLINASE; SULBACTAM;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; ISOELECTRIC FOCUSING; MINIMUM INHIBITORY CONCENTRATION;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; SULBACTAM;

EID: 0030009716     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.1.155     Document Type: Article

References (10)

1. Aubert, G., Grimont, F., Michel, V. P., Zeni, F., Pain, P., Vautrin, A. C. et al. (1994). Acinetobacter baumannii outbreak isolated characterized by three typing methods. In Program and Abstract of the Third International Meeting on Bacterial Epidemiological Markers, Cambridge, 1994. Abstract PB14.
2. Foulds, G., Knirsch, A. K., Stankewich, J. P. & Weildler, D. R. (1985). The parenteral kinetics of ampicillin/sulbactam in man. International Journal of Clinical Pharmacology Research 5, 79-86.
3. Hartstein, A. I., Rashad, A. L., Liebler, J. M., Actis, L. A., Freeman, J., Rourke, J. W. et al. (1988). Multiple intensive care unit outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infection and colonization associated with contaminated, reusable ventilator circuits and resuscitation bags. American Journal of Medicine 8, 624-31.
4. Joly-Guillo, M. L., Vallée, E., Bergogne-Bérézin, E. & Philippon, A. (1988). Distribution of β-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus. Journal of Antimicrobial Chemotherapy 22, 597-604.
5. Kitzis, M. D., Goldstein, F. W., Labia, R. & Acar, J. F. (1983). Activité du sulbactam et de l'acide clavulanique, seuls et associés sur Acinetobacter calcoaceticus. Annales de Microbiologie 134, 163-8.
6. Labia, R., Morand, A., Lelièvre, V., Mattioni, D. & Kazmierczak, A. (1986). Sulbactam: biochemical factors involved in its synergy with ampicillin. Review of Infectious Diseases 8, Suppl. 5, 496-502.
7. Paul, G., Joly-Guillou, M. L., Bergogne-Berezin, E., Névot, P. & Philippon, A. (1989). Novel carbenicillin-hydrolysing β-lactamase (CARB-5) from Acinetobacter calcoaceticus var. anitratus. FEMS Microbiology Letters 59, 45-50.
8. Retsema, J. A., English, A. R., Girard, A., Lynch, J. E., Anderson, M., Brennan, L. et al. (1986). Sulbactam/ampicillin: In vitro spectrum, potency and activity in models of acute infection. Reviews of Infectious Diseases 8, Suppl. 5, 528-34.
9. Seifert, H., Baginski, R., Schulze, A. & Pulverer, G. (1993). Antimicrobial susceptibility of Acinetobacter species. Antimicrobial Agents and Chemotherapy 37, 750-3.
10. Traub, W. H. & Spohr, M. (1989). Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6). Antimicrobial Agents and Chemotherapy 33, 1617-9.